help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ziecik, A. J.
Right arrow Articles by Tilton, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziecik, A. J.
Right arrow Articles by Tilton, J. E.

Endocrinology, Vol 119, 1159-1163, Copyright © 1986 by Endocrine Society


ARTICLES

Evidence for the presence of luteinizing hormone/human chorionic gonadotropin-binding sites in the porcine uterus

AJ Ziecik, PD Stanchev and JE Tilton

LH/hCG-binding sites were measured in crude membrane fractions of porcine uteri. Specific high affinity and low capacity receptors for LH/hCG were found in all (n = 17) membrane preparations of myometrium but in only 5 of 17 crude membrane fractions of endometrium of porcine uteri. There was very little competition between hCG and porcine GH (pGH), bovine TSH, pFSH, and pPRL (0.5%, 0.3%, 0.2%, and less than 0.005%, respectively). Specificity of [125I]hCG binding to other tissues was determined by incubating crude membrane preparations of heart, skeletal muscle, liver, and kidney. Numbers and affinities of available LH/hCG-binding sites were characterized in all samples of myometrium and 5 endometrium membrane preparations that were positive for LH/hCG receptors. The results indicate that the number of uterine LH-binding sites in myometrium (0.66 +/- 0.17 fmol/mg) is 10 times less than the receptor capacity in porcine corpora lutea (7.46 +/- 0.54 fmol/mg) when expressed per mg protein of crude membrane preparation. However, it is approximately 60 times less when expressed per mg DNA equivalent of initial homogenate (1.31 +/- 0.28 vs. 81.18 +/- 3.64 fmol/mg, respectively). Receptor affinities of uterine LH/hCG-binding sites remained comparable to those of corpora lutea receptors (Ka = 7.8 X 10(10) M-1). Concentrations of LH/hCG-binding sites in myometrium taken from gilts in the late follicular phase of the estrous cycle (0.13 +/- 0.06 fmol/mg protein; n = 5) were significantly less (P less than 0.05 and P less than 0.01) compared to those in myometrium from luteal phase (0.85 +/- 0.22 fmol/mg protein; n = 6) or early pregnancy (1.03 +/- 0.15 fmol/mg protein; n = 6), respectively. This is probably the first evidence demonstrating specific binding of [125I]hCG by LH receptors in female uterine tissue.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
G. Bodek, A. Kowalczyk, A. Waclawik, I. Huhtaniemi, and A. J. Ziecik
Targeted Ablation of Prostate Carcinoma Cells Through LH Receptor Using Hecate-CG{beta} Conjugate: Functional Characteristic and Molecular Mechanism of Cell Death Pathway
Experimental Biology and Medicine, June 1, 2005; 230(6): 421 - 428.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Perrier d'Hauterive, C. Charlet-Renard, S. Berndt, M. Dubois, C. Munaut, F. Goffin, M.-T. Hagelstein, A. Noel, A. Hazout, J.-M. Foidart, et al.
Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium
Hum. Reprod., November 1, 2004; 19(11): 2633 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. J. Fields and M. Shemesh
Extragonadal Luteinizing Hormone Receptors in the Reproductive Tract of Domestic Animals
Biol Reprod, November 1, 2004; 71(5): 1412 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Ascoli, F. Fanelli, and D. L. Segaloff
The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective
Endocr. Rev., April 1, 2002; 23(2): 141 - 174.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
E. A. Stewart
Gonadotropins and the Uterus: Is There a Gonad-Independent Pathway?
Reproductive Sciences, December 1, 2001; 8(6): 319 - 326.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
M. Zheng, H. Shi, D. L. Segaloff, and B. J. Van Voorhis
Expression and Localization of Luteinizing Hormone Receptor in the Female Mouse Reproductive Tract
Biol Reprod, January 1, 2001; 64(1): 179 - 187.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
S. You, H. Kim, C.-C. Hsu, M. E. El Halawani, and D. N. Foster
Three Different Turkey Luteinizing Hormone Receptor (tLH-R) Isoforms I: Characterization of Alternatively Spliced tLH-R Isoforms and Their Regulated Expression in Diverse Tissues
Biol Reprod, January 1, 2000; 62(1): 108 - 116.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
D. Mizrachi and M. Shemesh
Follicle-Stimulating Hormone Receptor and Its Messenger Ribonucleic Acid Are Present in the Bovine Cervix and Can Regulate Cervical Prostanoid Synthesis
Biol Reprod, September 1, 1999; 61(3): 776 - 784.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Shemesh, M. Gurevich, D. Mizrachi, L. Dombrovski, Y. Stram, M. J. Fields, and L. S. Shore
Expression of Functional Luteinizing Hormone (LH) Receptor and Its Messenger Ribonucleic Acid in Bovine Uterine Veins: LH Induction of Cyclooxygenase and Augmentation of Prostaglandin Production in Bovine Uterine Veins
Endocrinology, November 1, 1997; 138(11): 4844 - 4851.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society